MelanoDermTM Technical References
474. |
NEW! |
INHIBITORY EFFECTS OF A NOVEL ASCORBIC DERIVATIVE, DISODIUM ISOSTEARYL 2-O-L-ASCORBYL PHOSPHATE ON MELANOGENESIS.
Matsuda1, S., Shibayama1,2, H., Hisama1, M., Ohtsuki2, M., and Iwaki3, M.
1Central Research Center, Toyo Beauty Co., Ltd.; 3–13–8 Higashinakamoto, Higashinari-ku, Osaka 537–0021, Japan: 2Department of Dermatorogy, Jichi Medical University; 3311–1 Yakushiji, Shimotsuke, Tochigi 329–0498, Japan: and 3Faculty of Pharmaceutical Sciences, Kinki University; 3–4–1 Kowakae, Higashi-Osaka, Osaka 577–8502, Japan.
Chem. Pharm. Bull., 56(3) 292-297 (2008).
|
473. |
NEW! |
HUMAN SKIN RESPONSES TO UV RADIATION: PIGMENT IN THE UPPER EPIDERMIS PROTECTS AGAINST DNA DAMAGE IN THE LOWER EPIDERMIS AND FACILITATES APOPTOSIS.
Yamaguchi1, Y., Takahashi1, K., Zmudzka2, B.Z., Kornhauser3, A., Miller2, S.A., Tadokoro1, T., Berens1, W., Beer2, J.Z., and Hearing1, V.J.
1Laboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA; 2Center for Devices and Radiological Health, Food and Drug Administration, Rockville, Maryland, USA; and 3Center for Food Safety and Applied Nutrition, U. S. Food and Drug Administration, College Park, Maryland, USA.
FASEB J., 20,, E630-E639 (2006).
|
471. |
NEW! |
SOX9 IS A KEY PLAYER IN ULTRAVIOLET B-INDUCED MELANOCYTE DIFFERENTIATION AND PIGMENTATION.
Passeron1, T., Valencia1, J.C., Bertolotto2, C., Hoashi1, T., Le Pape1, E., Takahashi1, K., Ballotti2, R., and Hearing1, V.J.
1
1Pigment Cell Biology Section, Laboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20814; and 2Unite 597, Institut National de la Sante et de la Recherche Medicale, Faculte de Medecine, Universite de Nice Sophia–Antipolis, 06103 Nice, France.
PNAS, 104, 35, 13984-13989, (2007).
|
470. |
NEW! |
DICKKOPF 1 (DKK1) REGULATES SKIN PIGMENTATION AND THICKNESS BY AFFECTING WNT/β-CATENIN SIGNALING IN KERATINOCYTES.
Yamaguchi1,2,3, Y., Passeron1, T., Hoashi1, T., Watabe1, H., Rouzaud1, F., Yasumoto1, K., Hara1, T., Tohyama2, C., Katayama2, I., Miki1, T., and Hearing1, V.J.
1Laboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA; 2Department of Dermatology, Osaka University Graduate School of Medicine, Osaka, Japan; and 3Department of Geriatric and Environmental Dermatology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
FASEB J., 22, 000–000 (2008).
|
460. |
NEW! |
EVALUATION OF COSMETIC INGREDIENTS IN TISSUE ENGINEERED HUMAN SKIN IN VITRO.
Osborne, R., Mullins, L.A., Jarrold, B.B., McPhail, S., Robinson, L.
The Procter & Gamble Company, Cincinnati, Ohio USA.
Presented at American Association for Advancement of Science Annual Meeting (2007)
|
393. |
NEW! |
SUPPRESSED PERMEATION OF LINOLEIC ACID IN A LIPOSOMAL FORMULATION THROUGH RECONSTRUCTED SKIN TISSUE.
Shigeta1, Y., Imanaka2, H., Yonezawa3, S., Oku3, N., Baba1, N., Miakino2, T.
1Okayama University Graduate School of Natural Science and Technology, 3-1-1 Tsushimanaka, Okayama 700-8530, Japan. 2R&D, SUNSTAR INC, 3-1 Asahi-machi, Takatsuki 569-1195. 3Department of Medical Biochemistry, University of Shizuoka School of Pharmaceutical Sciences, 52-1 Yada, Shizuoka 422-8526, Japan.
Biol. Pharm. Bull., 27, 879-882, (2004).
|
387. |
NEW! |
PROTECTING THE SKIN AGAINST OZONE.
Gruber1, J.V., Tay1, A., Holtz2, R.
1Arch Personal Care Products, South Plainfield, NJ; 2Bioinnovation Laboratories, Inc., McKinney, TX.
Journal of Cosmetic Sciences, 56, (5), 348-349, (2005).
|
371. |
|
IN VITRO SKIN EQUIVALENT MODELS FOR TOXICITY TESTING.
Hayden, P.J., Ayehunie, S., Jackson, G.R., Kupfer-Lamore, S., Last, T.J., Klausner, M., Kubilus, J.
MatTek Corporation, Ashland, MA, U.S.A.
Published in Alternative Toxicological Methods. Editors H. Salem, S.A. Katz. CRC Press LLC, Boca Raton, FL, USA, 229-247 (2003).
|
329. |
|
A NATURAL NEW ACTIVE WHITENING MOLECULE.
Daffix1, C., Lemesle1, A, Robert1, C., Rabhi2, C.; Pouligon2, M., Jean2, D., Schwaab1, V.
1Department of Biology, LMD Pharmacognosie, Veyre-Monton, France. 2Department of Chemistry, LMD Pharmacognosie, Veyre-Monton, France.
J. Invest. Dermatol., 122, (3), A157, Abstract #939, (2004).
|
302. |
|
RECONSTITUTED 3-DIMENSIONAL HUMAN SKIN OF VARIOUS ETHNIC ORIGINS AS AN IN VITRO MODEL FOR STUDIES OF PIGMENTATION.
Yoon1,2, T.J., Lei2, T.C., Yamaguchi2, Y., Batzer3, J., Wolber3, R., Hearing2, V.J.
1Gyeongsang National University Hospital, Gyeongnam, South Korea, 2National Cancer Institute, Bethesda, MD, 3R&D Cosmed, Skin Research, Beiersdorf AG, Hamburg, Germany.
Analytical Biochemistry, 318, (2), 260-269, (2003).
|
264. |
|
RESULTS USING MELANODERM™, AN EPIDERMAL MODEL CONTAINING FUNCTIONAL MELANOCYTES, DEMONSTRATE EFFICACY OF NOVEL SKIN LIGHTENING FORMULATIONS.
Klausner, M., Kubilus, J., Hayden, P.J., Last, T.J., DePaoliAmbrosi*, G.
MatTek Corporation, Ashland, MA, *General Topics, s.r.l., San Felice del Benaco, Italy.
Presented at Soc. Invest. Derm. Meeting, May (2002).
|
249. |
|
THE PROTEASE-ACTIVATED RECEPTOR 2 REGULATES PIGMENTATION VIA KERATINOCYTE-MELANOCYTE INTERACTIONS.
Seiberg, M., Paine, C., Sharlow, E., Andrade-Gordon, P., Costanzo, M., Eisinger, M., Shapiro, S.S.
Skin Research Center, Johnson & Johnson CPWW, Skillman, New Jersey, 08558, USA.
Exp. Cell Res., 254(1), 25-32, (2000).
|
227. |
|
IMPROVEMENTS TO MELANODERM™, AN EPIDERMAL MODEL CONTAINING FUNCTIONAL MELANOCYTES FOR SKIN LIGHTENING STUDIES.
Klausner, M., Neal, P., Breyfogle, B., Kubilus, J.
MatTek Corp., Ashland, MA.
J. Invest. Dermatol., 117, (2), 513, Abstract #740, (2001).
|
226. |
|
COMPARISON OF FUNCTIONAL PIGMENTATION ASSAYS.
Nip, J.S., Barratt, M.J.
Skin Bioscience, Unilever Research US, Edgewater, NJ.
Presented at the 10th annual meeting of the PanAmerican Society of Pigmented Cell Research, Minneapolis, June 14-17, (2001).
|
220. |
|
AN ALTERNATIVE APPROACH TO DEPIGMENTATION BY SOYBEAN EXTRACT VIA INHIBITION OF THE PAR-2 PATHWAY.
Paine, C., Sharlow, E., Liebel, F., Eisinger, M., Shapiro, S., Seiberg, M.
Johnson and Johnson-Consumer Products Worldwide, Skin Research Center, Skillman, NJ.
J. Invest. Dermatol., 116, (4) 587-595, (2000).
|
218. |
|
A CELL PIGMENTATION ASSAY SUITABLE FOR SCREENING OF COSMETIC RAW MATERIALS.
Costello, B.
Collaborative Laboratories, Stonybrook, NY.
Journal of Cosmetic Science, 51, (1) 71, (2000).
|
211. |
|
MELANODERM, AN EPIDERMAL TISSUE TO EVALUATE SKIN LIGHTENING AND DARKENING.
Klausner, M., Neal, P., Breyfogle, B., Kubilus, J.
MatTek Corp., Ashland, MA.
Presented at the 21st International Federation of Societies of Cosmetic Chemists Congress, Berlin, Germany, September 11 – 14, (2000).
|
206. |
|
USE OF MELANODERM™, AN EPIDERMAL MODEL CONTAINING FUNCTIONAL MELANOCYTES TO STUDY MODULATORS OF SKIN PIGMENTATION.
Klausner, M., Neal, P., Breyfogle, B., Kubilus, J.
MatTek Corp., Ashland, MA.
J. of Invest. Dermatol., 115, 553, Abstract #142, (2000).
|
200. |
|
INHIBITION OF MELANOSOME TRANSFER RESULTS IN SKIN LIGHTENING.
Seiberg, M., Paine, C., Sharlow, E., Andrade-Gordon, P., Costanzo*, M., Eisinger*, M., Shapiro, S.S.
Skin Research Center, Johnson & Johnson CPWW, Skillman, New Jersey. U.S.A. *The R.W. Johnson Pharmaceutical Research Institute, Spring House, Pennsylvania, U.S.A.
J. Invest. Dermatol., 115, 162-167, (2000).
|
196. |
|
USE OF MELANODERM™, AN EPIDERMAL MODEL CONTAINING FUNCTIONAL MELANOCYTES, FOR SKIN LIGHTENING STUDIES.
Klausner, M., Breyfogle, B., Neal, P., Kubilus, J.
MatTek Corp., Ashland, Massachusetts
J. of Invest. Dermatol., 114, 859, Abstract #661, (2000).
|
188. |
|
THE PROTEASE-ACTIVATED RECEPTOR 2 REGULATES PIGMENTATION VIA KERATINOCYTE-MELANOCYTE INTERACTIONS.
Seiberg, M., Paine, C., Sharlow, E., Andrade-Gordon, P., Costanzo, M., Eisinger, M., Shapiro, S.S.
Skin Research Center, Johnson & Johnson CPWW, Skillman, NJ, 08558 USA.
Exp. Cell Res., 254(1), 25-32, (2000).
|
185. |
|
THE EFFECTS OF TROPOSPHERIC OZONE ON A HUMAN EPIDERMAL SKIN MODEL (EPIDERM).
Weber, S.U., Tavakkol*, A., Nabi*, Z., Jothi, S., Polefka*, T.G., Packer, L.
Department of Molecular and Cell Biology, University of California at Berkeley, Berkeley, California, *Personal Care Products, Colgate-Palmolive Co., Piscataway, New Jersey.
J. Invest. Dermatol., 112, 576, Abstract #323, (1999).
|
177. |
|
MELANODERM™: AN EPIDERMAL TISSUE MODEL CONTAINING FUNCTIONAL MELANOCYTES.
Klausner, M., Neal, P., Breyfogle, B., Kubilus, J.
MatTek Corp., Ashland, MA 01721, USA.
Presented at the 17th International Pigment Cell Conference, Nagoya, Japan Oct 30-Nov 4, 1999. Also published in ATLA, 27, 299, (1999).
|
173. |
|
NEW RESULTS WITH MELANODERM™, AN EPIDERMAL MODEL CONTAINING FUNCTIONAL MELANOCYTES.
Klausner, M., Neal, P., Breyfogle, B., Kubilus, J.
MatTek Corp., Ashland, MA.
Presented at the 1999 Annual Meeting of the Society of Investigative Dermatology, Chicago, IL. Abstract published in J. Invest. Dermatol., 112, 629, Abstr. #639 (1999).
|
171. |
|
EPIDERMAL STRATIFICATION REDUCES THE EFFECTS OF UVB (BUT NOT UVA) ON KERATINOCYTE CYTOKINE PRODUCTION AND CYTOTOXICITY.
Corsini2, E., Sangha1, N., Feldman2, S.N.
1Departments of Dermatology and Pathology, Bowman Grey School of Medicine, Wake Forest University, Winston Salem, NC, USA, 2Center for Cosmetic Toxicology, Institute of Pharmacological Sciences, University of Milan, Milan, Italy.
Photodermatol. Photoimmunol. Photomed., 13, 147-152, (1997).
|
163. |
|
MELANODERM™, AN EPIDERMAL MODEL CONTAINING FUNCTIONAL MELANOCYTES.
Klausner, M., Neal, P., Breyfogle, B., Kubilus, J.
MatTek Corp., Ashland, MA.
Presented at IBC 3rd Annual Conference on "Cosmeceuticals", Short Hills, NJ, February 4-5, (1999).
|
160. |
|
AN IN VITRO METHOD FOR SCREENING SKIN-WHITENING PRODUCTS.
Majmudar, G., Jacob, G., Laboy, Y., Fisher, L.
Mary Kay Holding Corp., Dallas, TX 75247.
J. Cosmet. Sci., 361-367, (1998).
|
151. |
|
MATTEK'S TISSUE MODELS: NEW DEVELOPMENTS.
Klausner, M.
MatTek Corp., Ashland, MA 01721.
Presented at International Business Conference, "Latest In Vitro Testing Methods for Skin Care, Cosmetics, and Household Products," Washington, D.C., (1997).
|
122. |
|
INITIAL CHARACTERIZATION OF AN EPIDERMAL MODEL CONTAINING FUNCTIONAL MELANOCYTES.
Klausner, M., Kubilus, J., Neal, P.J.
MatTek Corp., Ashland, MA.
J. Invest. Dermatology, 104(4), 616, Abstr. # 370 (1995).
|
|
|
